A Multicenter, Single Arm, Prospective, Open-Label, Staged Study of the Safety and Efficacy of the AuriNovo Construct for Auricular Reconstruction in Subjects With Unilateral Microtia
AuriNovo provides a patient-specific, biological construct for use in the surgical reconstruction of the external ear in people born with microtia Grades II-IV. This Phase 1 / 2A study is being conducted to collect preliminary safety data on microtic ear reconstruction using AuriNovo, fine-tune technical, logistical, surgical, and post-surgical care aspects related to implantation, and to gather preliminary efficacy data including short- and longer-term in vivo duration and biological status of the implant.
100 项与 3DBio Therapeutics, Inc. 相关的临床结果
0 项与 3DBio Therapeutics, Inc. 相关的专利（医药）
100 项与 3DBio Therapeutics, Inc. 相关的药物交易
100 项与 3DBio Therapeutics, Inc. 相关的转化医学
